Structural,
Mechanistic, and Ultradilute Catalysis
Portrayal of Substrate Inhibition in the TAML–Hydrogen Peroxide
Catalytic Oxidation of the Persistent Drug and Micropollutant, Propranolol
posted on 2018-09-05, 00:00authored byYogesh Somasundar, Longzhu Q. Shen, Alexis G. Hoane, Liang L. Tang, Matthew R. Mills, Abigail E. Burton, Alexander D. Ryabov, Terrence J. Collins
TAML activators enable unprecedented,
rapid, ultradilute oxidation
catalysis where substrate inhibitions might seem improbable. Nevertheless,
while TAML/H2O2 rapidly degrades the drug propranolol,
a micropollutant (MP) of broad concern, propranolol is shown to inhibit
its own destruction under concentration conditions amenable to kinetics
studies ([propranolol] = 50 μM). Substrate inhibition manifests
as a decrease in the second-order rate constant kI for H2O2 oxidation of the resting
FeIII-TAML (RC) to the activated catalyst (AC), while the
second-order rate constant kII for attack
of AC on propranolol is unaffected. This kinetics signature has been
utilized to develop a general approach for quantifying substrate inhibitions.
Fragile adducts [propranolol, TAML] have been isolated and subjected
to ESI-MS, florescence, UV–vis, FTIR, 1H NMR, and
IC examination and DFT calculations. Propranolol binds to FeIII-TAMLs via combinations of noncovalent hydrophobic, coordinative,
hydrogen bonding, and Coulombic interactions. Across four studied
TAMLs under like conditions, propranolol reduced kI 4–32-fold (pH 7, 25 °C) indicating that
substrate inhibition is controllable by TAML design. However, based
on the measured kI and calculated equilibrium
constant K for propranolol–TAML binding, it
is possible to project the impact on kI of reducing [propranolol] from 50 μM to the ultradilute regime
typical of MP contaminated waters (≤2 ppb, ≤7 nM for
propranolol) where inhibition nearly vanishes. Projecting from 50
μM to higher concentrations, propranolol completely inhibits
its own oxidation before reaching mM concentrations. This study is
consistent with prior experimental findings that substrate inhibition
does not impede TAML/H2O2 destruction of propranolol
in London wastewater while giving a substrate inhibition assessment
tool for use in the new field of ultradilute oxidation catalysis.